The effects of drugs is mainly explained by their action on specific r
eceptors located on target cells. However, the receptors are can be re
gulated by changes into the levels of the physiological neurotransmitt
er and/or by drugs. A chronic treatment by an agonist induces a desens
itization leading to a decrease in cellular response. The desensitizat
ion is ''homologous'' when if only involves the activated pathway and
''heterologous'' when a decrease in the response to of her factors (tr
ansmitters, drugs) appears. At the molecular level, desensitization is
explained by covalent modification of the receptors by phosphorylatio
n catalyzed by a variety of protein kinases. A long term stimulation e
licits an internalization of the receptor followed by degradation : th
is mechanism is called ''down regulation''. In contrast, treatment wit
h antagonists can induce hypersensitization (ie. increase in the cellu
lar response) with up regulation. The consequences of these notions ar
e discussed in term of both clinical pharmacology and pharmacovigilanc
e.